Sp140
PANEL DISCUSSION
Date
May 18, 2024
Presenters
University of California san francisco
University of North Carolina School of Medicine
University of Chicago Division of the Biological Sciences
Tracks
Related Products
IMIBD Late Breakers and Innovations in IBD
SOCIETY: AGA By popular demand, this new session highlights the best late-breakers submitted to the IBD section and well as innovations in technology and new paradigms of care in IBD
ENVIRONMENTAL AND DIETARY FACTORS IN INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED CASE-CONTROL STUDY FROM THE GLOBAL INFLAMMATORY BOWEL DISEASE VISUALIZATION OF EPIDEMIOLOGY STUDIES IN THE 21ST CENTURY (GIVES-21) CONSORTIUM
OBJECTIVE:The rapid emergence of IBD in newly industrialized regions supports the importance of environmental risk factors in disease etiology…
PREGNANCY OUTCOMES AFTER MATERNAL OR PATERNAL EXPOSURE IN THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM
BACKGROUND: Pregnant women with ulcerative colitis (UC) have a higher risk of adverse pregnancy outcomes vs age-matched controls.1 Tofacitinib is an oral Janus kinase inhibitor for the treatment of UC. There are no well-controlled studies on tofacitinib use in pregnant women…
